The AngelMed Guardian system: is there a role for implantable devices for early detection of coronary artery occlusion?

The AngelMed Guardian System is an implantable device similar to a single chamber pacemaker that continuously monitors the intracardiac electrogram for evidence of ST segment shift indicating acute coronary artery occlusion. The system aims to reduce time to presentation by alerting patients to present to a medical facility whether symptoms are present or not. In March 2016, the US Food and Drug Administration (FDA) assembled a meeting of the Circulatory System Devices Panel to review the results of the AngelMed for Early Recognition and Treatment of STEMI (ALERTS) pivotal trial and the accompanying premarket approval (PMA) application for regulatory approval of the AngelMed Guardian System in the US.

Source: Cardiovascular Revascularization Medicine - October 6, 2016 Category: Cardiology Authors: Toby Rogers, Arik Steinvil, Rebecca Torguson, Ron Waksman Source Type: research